Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SHC2 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → SHC2 |
| (<<) BCL6 → SHC2 |
| (<<) CBS → SHC2 |
| (<<) CTSF → SHC2 |
| (<<) GPX3 → SHC2 |
| (<<) MT1P2 → SHC2 |
| (<<) PTMA → SHC2 |
| (<<) SOD1 → SHC2 |
| (<<) ST3GAL6 → SHC2 |
| Downstream (Children) |
|---|
| SHC2 → ADAM17 (>>) |
| SHC2 → ADCY3 (>>) |
| SHC2 → ARSA (>>) |
| SHC2 → BAD (>>) |
| SHC2 → CISH (>>) |
| SHC2 → CKB (>>) |
| SHC2 → DUSP10 (>>) |
| SHC2 → ENO1 (>>) |
| SHC2 → FZD3 (>>) |
| SHC2 → IFITM3 (>>) |
| SHC2 → INPP5D (>>) |
| SHC2 → KLF11 (>>) |
| SHC2 → MLXIPL (>>) |
| SHC2 → NRG1 (>>) |
| SHC2 → PPP1R3D (>>) |
| SHC2 → RHOB (>>) |
| SHC2 → T (>>) |
